PBYI vs STTK
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
PBYI · Puma Biotechnology$7.05 ▼ 0.98%
STTK · Shattuck Labs$4.46 ▼ 1.98%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- PBYI +41.6%
- STTK +116.5%
Head to head
| Metric | PBYI | STTK |
|---|---|---|
| Price | $7.05 | $4.46 |
| Change today | ▼ 0.98% | ▼ 1.98% |
| Market cap | $364.47M | $454.22M |
| Return, 3 months | -22.7% | -43.5% |
| Return, year to date | +18.5% | +22.2% |
| Return, 1 year | +44.2% | +119.7% |
| P/E (TTM) | 15.3 | – |
| P/B | 2.5 | 2.3 |
| P/E percentile vs own 5y | 76th | 10th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +1.1% | -100.0% |
| Net profit growth (YoY) | -32.7% | -150.6% |
| Gross margin | 73.6% | – |
| Operating margin | 11.3% | – |
| Net margin | 10.3% | – |
| Return on equity | 18.2% | -47.2% |
| Analyst target vs. price | – | +242.8% |
| Analyst buy share | – | 100% |
| RSI (14) | 24 | 35 |
| 30-day volatility | 69.1% | 73.9% |
| Max drawdown, 1 year | -37.4% | -50.5% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- STTK is the largest of the group by market value.
- STTK has returned the most over the past year.
- PBYI is growing revenue fastest.
- PBYI has been the calmest stock over the last 30 days.